186
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluations

Guidelines for the use of extended-release nevirapine in HIV-infected patients

, PharmD BCPS & , PharmD BCPS FCCP AAHIVE
Pages 2713-2718 | Published online: 29 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eric W Pefura Yone & André P Kengne. (2012) Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment. HIV/AIDS - Research and Palliative Care 4, pages 181-184.
Read now

Articles from other publishers (2)

Monica R. P. Rao, Sharwari Sapate & Ashwini Sonawane. (2022) Pharmacotechnical Evaluation by SeDeM Expert System to Develop Orodispersible Tablets. AAPS PharmSciTech 23:5.
Crossref
Katherine J Lepik, Benita Yip, Rachel A McGovern, Erin Ding, Adriana Nohpal, Birgit E Watson, Junine Toy, Linda Akagi, P Richard Harrigan, David M Moore, Robert S Hogg, Julio SG Montaner & Rolando Barrios. (2014) Post-Marketing Experience with Nevirapine Extended Release (XR) Tablets: Effectiveness and Tolerability in a Population-Based Cohort in British Columbia, Canada. Antiviral Therapy 20:7, pages 721-730.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.